首页> 外文期刊>American Journal of Cancer Research >Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219
【24h】

Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219

机译:长非编码RNA TUG1通过使miR-219变海绵状上调FMNL2来促进口腔鳞状细胞癌的发展

获取原文
           

摘要

Oral squamous cell carcinoma (OSCC) is a prevalent oral disease with a high morbidity and mortality rate. Several long non-coding RNAs (lncRNAs) were identified as important regulators of carcinogenesis. However, the pathogenic implications of TUG1 in OSCC are still unclear. In the present study, the expression of TUG1 was increased in OSCC cells. Knockdown of TUG1 inhibited cell proliferation, migration, and invasion, and induced cell cycle arrest at G0/G1 phase, whereas overexpression of TUG1 exerted the opposite effect on OSCC cells. A reciprocal repressive interaction between TUG1 and miR-219 was found, and miR-219 inhibition abolished the tumor-suppressive effect of TUG1 knockdown on cell growth and motility. Furthermore, bioinformatics analysis and luciferase reporter assay showed that FMNL2 was a direct target of miR-219. Restoration of FMNL2 abrogated the miR-219-induced inhibition of cell proliferation, cell cycle progression, migration, and invasion. Besides, overexpression of TUG1 promoted tumor growth and metastasis in vivo. Clinically, the expression of TUG1 and FMNL2 were increased, but miR-219 was decreased in primary tumors compared to non-tumor tissues. Both the upregulated TUG1, and FMNL2 and the downregulated miR-219 was associated with advanced stage of OSCC and poor overall survival. Notably, multivariate analyses confirmed that FMNL2 was an independent risk factor for OSCC. In conclusion, our data revealed that TUG1 confers oncogenic function in OSCC and TUG1/miR-219/FMNL2 axis may be a novel therapeutic strategy in this disease.
机译:口腔鳞状细胞癌(OSCC)是一种常见的口腔疾病,发病率和死亡率很高。几个长的非编码RNA(lncRNA)被确定为致癌作用的重要调节剂。但是,TUC1在OSCC中的致病意义尚不清楚。在本研究中,在OSCC细胞中TUG1的表达增加了。敲低TUG1抑制细胞增殖,迁移和侵袭,并诱导细胞周期停滞在G0 / G1期,而TUG1的过表达对OSCC细胞产生相反的作用。发现在TUG1和miR-219之间存在相互抑制性相互作用,并且miR-219的抑制作用消除了TUG1敲低对细胞生长和运动性的肿瘤抑制作用。此外,生物信息学分析和荧光素酶报告基因分析表明,FMNL2是miR-219的直接靶标。 FMNL2的恢复取消了miR-219诱导的细胞增殖,细胞周期进程,迁移和侵袭的抑制。此外,TUG1的过表达促进了体内肿瘤的生长和转移。临床上,与非肿瘤组织相比,原发肿瘤中TUG1和FMNL2的表达增加,但miR-219减少。 TUG1和FMNL2的上调以及miR-219的下调均与OSCC晚期和总体生存期差有关。值得注意的是,多变量分析证实FMNL2是OSCC的独立危险因素。总之,我们的数据显示TUG1在OSCC中赋予致癌功能,而TUG1 / miR-219 / FMNL2轴可能是该疾病的一种新型治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号